{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T22:40:25Z","timestamp":1782513625283,"version":"3.54.5"},"reference-count":13,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001861","name":"Forskningsr\u00e5det f\u00f6r Arbetsliv och Socialvetenskap","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001861","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004047","name":"Karolinska Institutet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004047","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","contraceptionjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contraception"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1016\/j.contraception.2011.08.009","type":"journal-article","created":{"date-parts":[[2011,9,29]],"date-time":"2011-09-29T16:46:02Z","timestamp":1317314762000},"page":"394-397","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Assessment of significant factors affecting acceptability of home administration of misoprostol for medical abortion"],"prefix":"10.1016","volume":"85","author":[{"given":"Helena","family":"Kopp Kallner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Fiala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina","family":"Gemzell-Danielsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.contraception.2011.08.009_bb0005","first-page":"353","article-title":"Vaginal misoprostol administered at home after mifepristone (RU486) for abortion","volume":"44","author":"Schaff","year":"1997","journal-title":"J Fam Pract"},{"key":"10.1016\/j.contraception.2011.08.009_bb0010","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0010-7824(00)00186-4","article-title":"Analgesia during at-home use of misoprostol as part of a medical abortion regimen","volume":"62","author":"Westhoff","year":"2000","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2011.08.009_bb0015","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1097\/01.AOG.0000258298.35143.d2","article-title":"Mifepristone and misoprostol administered simultaneously versus 24 hours apart for abortion: a randomized controlled trial","volume":"109","author":"Creinin","year":"2007","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2011.08.009_bb0020","doi-asserted-by":"crossref","unstructured":"Winikoff B. Acceptability of medical abortion in early pregnancy. Fam Plann Perspect 1995;27:142-8, 85.","DOI":"10.2307\/2136257"},{"key":"10.1016\/j.contraception.2011.08.009_bb0025","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0010-7824(00)00090-1","article-title":"Predictors of analgesia use during supervised medical abortion. The Mifepristone Clinical Trials Group","volume":"61","author":"Westhoff","year":"2000","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2011.08.009_bb0030","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.contraception.2004.06.005","article-title":"Acceptability of home-use of misoprostol in medical abortion","volume":"70","author":"Fiala","year":"2004","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2011.08.009_bb0035","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1093\/humrep\/deq037","article-title":"Home self-administration of vaginal misoprostol for medical abortion at 50-63 days compared with gestation of below 50 days","volume":"25","author":"Kopp Kallner","year":"2010","journal-title":"Hum Reprod"},{"key":"10.1016\/j.contraception.2011.08.009_bb0040","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1080\/13625180500284581","article-title":"Home use of two doses of misoprostol after mifepristone for medical abortion: a pilot study in Sweden and France","volume":"10","author":"Clark","year":"2005","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.contraception.2011.08.009_bb0045","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1111\/j.1471-0528.2004.00538.x","article-title":"The acceptability of home medical abortion to women in UK settings","volume":"112","author":"Hamoda","year":"2005","journal-title":"BJOG"},{"key":"10.1016\/j.contraception.2011.08.009_bb0050","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1783\/147118910790290894","article-title":"Women's opinions on the home management of early medical abortion in the UK","volume":"36","author":"Lohr","year":"2010","journal-title":"J Fam Plann Reprod Health Care"},{"key":"10.1016\/j.contraception.2011.08.009_bb0055","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1136\/bmj.307.6906.714","article-title":"Comparison of medical abortion with surgical vacuum aspiration: women's preferences and acceptability of treatment","volume":"307","author":"Henshaw","year":"1993","journal-title":"BMJ"},{"key":"10.1016\/j.contraception.2011.08.009_bb0060","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1111\/j.1471-0528.2004.00235.x","article-title":"Analgesia requirements and predictors of analgesia use for women undergoing medical abortion up to 22 weeks of gestation","volume":"111","author":"Hamoda","year":"2004","journal-title":"BJOG"},{"key":"10.1016\/j.contraception.2011.08.009_bb0065","series-title":"Abortion: expanding access and improving quality. Robert H. Ebert Program on Critical Issues in Reproductive Health working paper","author":"Stein","year":"1998"}],"container-title":["Contraception"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782411004823?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782411004823?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T20:09:49Z","timestamp":1757880589000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010782411004823"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4]]},"references-count":13,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["S0010782411004823"],"URL":"https:\/\/doi.org\/10.1016\/j.contraception.2011.08.009","relation":{},"ISSN":["0010-7824"],"issn-type":[{"value":"0010-7824","type":"print"}],"subject":[],"published":{"date-parts":[[2012,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessment of significant factors affecting acceptability of home administration of misoprostol for medical abortion","name":"articletitle","label":"Article Title"},{"value":"Contraception","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.contraception.2011.08.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}